Broker tips: Antofagasta, Spirax-Sarco, Smith & Nephew
10th Aug 2023 12:01
(Sharecast News) - Canaccord Genuity has maintained its 'buy' recommendation on miner Antofagasta despite the firm cutting its output forecasts on Thursday.
Read moreMajor upside potential at Smith & Nephew, says Berenberg
10th Aug 2023 11:07
(Sharecast News) - Berenberg has kept its 'buy' rating on Smith & Nephew after the medical equipment manufacturer's first-half results last week, giving an optimistic take on its current turnaround strategy.
Read moreSmith+Nephew lifts annual revenue guidance
3rd Aug 2023 07:33
(Sharecast News) - Medical products maker Smith+Nephew on Thursday lifted its full-year revenue outlook as first-half results were boosted by outperformance in its sports medicine and advanced wound management divisions.
Read moreDirector dealings: Smith & Nephew executives offload shares
3rd May 2023 12:33
(Sharecast News) - Medical technology company Smith & Nephew disclosed two executive share sales on Wednesday, with its shares remaining flat after the announcement.
Read moreSmith & Nephew Q1 revenues grow, reiterates FY guidance
26th Apr 2023 08:05
(Sharecast News) - Medical equipment manufacturer Smith & Nephew reiterated its full-year guidance on Wednesday after seeing revenues improve in the first quarter.
Read moreLiberum upgrades Smith & Nephew to 'buy'
1st Mar 2023 14:05
(Sharecast News) - Liberum upgraded Smith & Nephew on Wednesday to 'buy' from 'hold' and hiked the price target to 1,410p from 1,120p, saying it would look to buy on dips given the recent run.
Read moreSmith & Nephew confident despite slip in profits
21st Feb 2023 07:23
(Sharecast News) - Medical technology company Smith & Nephew reported full-year revenue of $5.22bn (£4.35bn) on Tuesday, which was up 4.7% on an underlying basis year-on-year.
Read moreSmith+Nephew appoints former Serco CEO Soames as chair
17th Feb 2023 07:25
(Sharecast News) - Medical technology company Smith+Nephew said it had appointed former Serco chief executive Rupert Soames as chair, succeeding Roberto Quarta who will this year.
Read moreSmith & Nephew Q3 revenues touch lighter than expected
3rd Nov 2022 07:23
(Sharecast News) - Medical equipment maker Smith & Nephew posted slightly lower-than-expected third-quarter revenues on Thursday as it said revenue growth for the full year was set to be in the middle of the previously guided range.
Read moreCredit Suisse and Barclays lower target price on Smith&Nephew
4th Aug 2022 15:29
(Sharecast News) - Analysts at Credit Suisse lowered their target price for shares of Smith&Nephew after what they described as a "mixed" set of interim results.
Read moreCost headwinds hit revenue, trading profit at Smith & Nephew
28th Jul 2022 10:12
(Sharecast News) - Smith & Nephew reported second quarter revenue of $1.29bn on Thursday, up 1.2% on an underlying basis but down 3.1% on a reported basis including a 430 basis point foreign exchange headwind.
Read moreSmith+Nephew Q1 revenues beat forecasts as elective surgeries resume
28th Apr 2022 08:13
(Sharecast News) - Medical products maker Smith+Nephew beat first quarter revenue forecasts as elective surgery volumes from the impact of the Omicron Covid variant at the start of the year.
Read moreRBC Capital starts Smith & Nephew at 'outperform'
16th Mar 2022 10:26
(Sharecast News) - RBC Capital Markets initiated coverage of medical products manufacturer Smith & Nephew at 'outperform' on Wednesday with a 1,700p price target.
Read moreSmith & Nephew FY operating profits double, CEO to depart
22nd Feb 2022 07:02
(Sharecast News) - Medical equipment manufacturer Smith & Nephew said on Tuesday that full-year operating profits had doubled in 2021, partly driven by a solid performance in its sports medicine and ENT and advanced wound management units.
Read moreBerenberg slightly raises target price on Smith & Nephew
17th Dec 2021 12:23
(Sharecast News) - Analysts at Berenberg raised their target price on medical services firm Smith & Nephew from £18.25 to £18.40 on Friday following the firm's "extensive meet-the-management event" a day earlier.
Read more